WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Cymbalta 2, Clinical Pharmacology Pharmacokinetics, Clinical Pharmacology Mechanism of Action Unknown precise mechanism regarding central pain inhibition and anxiolytic actions; believed to be related to potentiation of serotonergic and nonadrenergic activity in CNS, Indications and Usage ???? Generalized Anxiety Disorder, Warnings Carcinogenesis ????, Dosage Forms (delayed-release capsules) 30 milligram (blue and white capsule, printed "Lilly 3240 30 mg"), Clinical Pharmacology Indications and Usage, Indications and Usage ???? Chronic Musculoskeletal Pain, Warnings Adverse Reactions Pediatrics Decreased weight, decreased appetite, nausea, vomiting, fatigue, diarrhea In pediatric patients aged 7-17 years old with GAD/MDD Nausea, diarrhea, decreased weight, dizziness, 30 milligram (blue and white capsule, printed "Lilly 3240 30 mg") Contains: 33.7mg duloxetine hydrochloride Inactive ingredients: FD&C Blue No. 2, gelatin, hypromellose, hydroxypropyl methylcellulose acetate succinate, sodium laurel sulfate, sucrose, sugar spheres, talc, titanium dioxide, triethyl citrate, 60 milligram (blue and green capsule) Available formulations Printed "Lilly 3270 60mg", Indications and Usage ???? Fibromyalgia, Major Depressive Disorder ???? Indications and Usage, Dosage Forms (delayed-release capsules) 60 milligram (blue and green capsule), Clinical Pharmacology Warnings, Pharmacokinetics Special Population Considerations Pediatrics Average steady-state concentration 30% lower in pediatric population, Drug Class Selective serotonin and norepineprhine reuptake inhibitor (SNRI), 60 milligram (blue and green capsule) Available formulations Printed "Lilly 3237 60mg", "Depression hurts" campaign Evaluative Conditioing Behavioral, Inactive ingredients: FD&C Blue No. 2, gelatin, hypromellose, hydroxypropyl methylcellulose acetate succinate, sodium laurel sulfate, sucrose, sugar spheres, talc, titanium dioxide, triethyl citrate Contains: 22.4mg duloxetine hydrochloride, iron oxide yellow 20 milligram (green capsule, printed "Lilly 3235 20mg"), Pharmacokinetics Special Population Considerations Renal Impairment